Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This surveillance is conducted to survey the followings under the post marketed drug
utilization on the patients who are administrated ENBREL as a treatment for active
polyarticular JIA.
1. Primary Occurrence status of Adverse Events; incidence of all adverse events, serious
adverse events
2. Secondary Factors affecting safety and to confirm the efficacy such as DAS28.